Artiva Biotherapeutics, Inc. ARTV Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $71.8M+3.2% | $69.54M+5.6% | $65.86M+6.7% | $61.75M+9.8% | $56.23M+11.7% | ||
| $20.27M0.0% | $20.27M-0.1% | $20.28M+2.3% | $19.83M+5.8% | $18.74M+8.9% | ||
| $92.07M+2.5% | $89.81M+4.3% | $86.15M+5.6% | $81.58M+8.8% | $74.96M+11.0% | ||
| -$92.07M-2.5% | -$89.81M-4.3% | -$86.15M-5.6% | -$81.58M-8.8% | -$74.96M-11.4% | ||
| $5M-15.9% | $5.95M-14.5% | $6.96M+7.8% | $6.45M+99.0% | $3.24M+69.6% | ||
| -$87.07M-3.8% | -$83.87M-5.9% | -$79.19M-5.4% | -$75.13M-4.8% | -$71.72M-9.7% | ||
| -$3.54-3.5% | -$3.42— | —— | —— | —— | ||
| -$89.43M-2.5% | -$87.21M-4.3% | -$83.6M-5.7% | -$79.07M-9.1% | -$72.49M-11.8% | ||
| -$92.07M-2.5% | -$89.81M-4.3% | -$86.15M-5.6% | -$81.58M-8.8% | -$74.96M-11.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Artiva Biotherapeutics, Inc. profitable?
- Artiva Biotherapeutics, Inc. is not currently profitable: it reported a net loss of $87.1M over the trailing twelve months, a -79.3% net margin.
- What is Artiva Biotherapeutics, Inc.'s earnings per share?
- Artiva Biotherapeutics, Inc.'s diluted EPS over the trailing twelve months is $-3.54.
- Where does Artiva Biotherapeutics, Inc.'s income statement data come from?
- Every line is extracted from Artiva Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.